Analgesics - Uruguay

The preference of medical professionals and consumers for ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs), with the exception of dipyrone, continued to fuel analgesics OTC sales during 2009. NSAIDs, including most combination drugs, account for more than 70% of total value sales within the area, even when taking into account the decline of dipyrone sales. NSAIDs continue to provide consumers with fast relief to different types of pain and, when used either as a single drug or...

Euromonitor International's Analgesics Products in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.